Amneal Pharmaceuticals, Inc. (AMRX)
17.01
+0.14
(+0.83%)
USD |
NASDAQ |
Sep 11, 16:00
17.00
-0.01
(-0.06%)
After-Hours: 20:00
Amneal Pharmaceuticals Max Drawdown (5Y) : 94.77% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 94.77% |
| July 31, 2026 | 94.77% |
| June 30, 2026 | 94.77% |
| May 31, 2026 | 94.77% |
| April 30, 2026 | 94.77% |
| March 31, 2026 | 94.77% |
| February 28, 2026 | 94.77% |
| January 31, 2026 | 94.77% |
| December 31, 2025 | 94.77% |
| November 30, 2025 | 94.77% |
| October 31, 2025 | 94.77% |
| September 30, 2025 | 94.77% |
| August 31, 2025 | 94.77% |
| July 31, 2025 | 94.77% |
| June 30, 2025 | 94.77% |
| May 31, 2025 | 94.77% |
| April 30, 2025 | 94.77% |
| March 31, 2025 | 94.77% |
| February 28, 2025 | 94.77% |
| January 31, 2025 | 94.77% |
| December 31, 2024 | 94.77% |
| November 30, 2024 | 94.77% |
| October 31, 2024 | 94.77% |
| September 30, 2024 | 94.77% |
| August 31, 2024 | 94.77% |
| Date | Value |
|---|---|
| July 31, 2024 | 94.77% |
| June 30, 2024 | 94.77% |
| May 31, 2024 | 94.77% |
| April 30, 2024 | 94.77% |
| March 31, 2024 | 94.77% |
| February 29, 2024 | 94.77% |
| January 31, 2024 | 94.77% |
| December 31, 2023 | 94.77% |
| November 30, 2023 | 94.77% |
| October 31, 2023 | 94.77% |
| September 30, 2023 | 94.77% |
| August 31, 2023 | 94.77% |
| July 31, 2023 | 94.77% |
| June 30, 2023 | 94.77% |
| May 31, 2023 | 94.77% |
| April 30, 2023 | 94.77% |
| March 31, 2023 | 94.77% |
| February 28, 2023 | 91.92% |
| January 31, 2023 | 91.92% |
| December 31, 2022 | 91.92% |
| November 30, 2022 | 91.92% |
| October 31, 2022 | 91.92% |
| September 30, 2022 | 91.68% |
| August 31, 2022 | 91.06% |
| July 31, 2022 | 90.56% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Liquidia Corp. | 93.11% |
| Eli Lilly & Co. | 34.47% |
| Viatris, Inc. | 81.23% |
| Harmony Biosciences Holdings, Inc. | 68.48% |
| ANI Pharmaceuticals, Inc. | 72.96% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 10.41 |
| Beta (5Y) | 1.239 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 49.98% |
| Historical Sharpe Ratio (5Y) | 0.4332 |
| Historical Sortino (5Y) | 0.6619 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 20.46% |